COMPARE · Data as of August 21, 2026

IX vs NMR

Verdict: Side-by-side breakdown using the Bull Rankings model. IX scored 77.0, NMR scored 69.0 — IX leads.
Compare another set
IX
ORIX Corporation
Financial Conglomerates · Financial strength
68.7Fin
$38.49 · $41.8B
Strength gap
0.3
NMR leads
NMR
Nomura Holdings, Inc.
Capital Markets · Financial strength
69Fin
$9.72 · $28.4B
  • CheapestIX10.8x
  • Fastest growthIX+18.6%
THE BULL RANKINGS SCORECARD68.7/ 100 · FIN STRENGTHPEER MEDIANFINANCIAL68.7
THE BULL RANKINGS SCORECARD69.0/ 100 · FIN STRENGTHPEER MEDIANFINANCIAL69.0
cheap & fastrevenue growth →← cheaper (lower multiple)1%29%5.8x17xIXNMR

Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.

RevIX+18.6%NMR+10.8%
P/EIX10.8xNMR11.6x
IX
NMR
+18.6%B+
Rev
+10.8%B
1.30C+
D/E
10.8xA-
P/E
11.6xB+
2.72C
PEG
ROE
11.2%B
P/B
1.15B+
Yield
3.4%B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
IXORIX Corporation
Financial Conglomerates · $38.49 · beta 0.72
Why now
Financial Conglomerates · market cap $41.8b. 9% off the 52-week high of $42.39. Revenue growing +19%, comfortably above the S&P median.
Moat
Net margin 18% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 14% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
NMRNomura Holdings, Inc.
Capital Markets · $9.72 · beta 0.60
Why now
Capital Markets · market cap $28.4b. 3% off the 52-week high of $10.06. Revenue growing +11%, comfortably above the S&P median. PEG 0.81 — paying under fair value for the growth rate.
Moat
Net margin 17% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 11% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
D/E 9.46 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Balance-sheet financial — book value, net interest margin, and credit loss provisions are the lever points; a rates regime change or a deterioration in the loan book moves the stock more than EPS does.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.